Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Asian Regulatory News (ATR)

Share Price Information for Schroder Asian (ATR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 456.00
Bid: 451.00
Ask: 456.00
Change: 2.00 (0.44%)
Spread: 5.00 (1.109%)
Open: 447.00
High: 456.00
Low: 447.00
Prev. Close: 454.00
ATR Live PriceLast checked at -
Schroder Asian Total Return is an Investment Trust

To provide a high rate of total return primarily through investment in equity and equity related securities in Asia Pacific Region (excluding Japan).

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

11 Sep 2020 07:00

RNS Number : 6786Y
Schroder Asian Total Retn InvCo PLC
11 September 2020
 

11 September 2020

Half Year Report

 

Schroder Asian Total Return Investment Company plc hereby submits its Half Year Report for the period ended 30 June 2020 as required by the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 4.2.

 

The Half Year Report is also being published in hard copy format and an electronic copy of that document will shortly be available to download from the Company's webpage. Please click on the following link to view the document:

 

http://www.rns-pdf.londonstockexchange.com/rns/6786Y_1-2020-9-10.pdf

 

The Company has submitted a copy of its Half Year Report to the National Storage Mechanism and it will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Enquiries:

 

Benjamin Hanley

Schroder Investment Management Limited Tel: 020 7658 3847

 

 

 

 

Half year report and accounts for the six months ended 30 June 2020

 

Chairman's Statement

 

Performance

 

This is my first statement to shareholders as Chairman. The previous Chairman, David Brief, reported to shareholders in the annual report as at 31 December 2019, that since Schroders' appointment in March 2013, the Company's net asset value ("NAV") total return and share price total return had comfortably outperformed the Reference Index. The board would like to thank David for his contributions as director and Chairman.

 

I am extremely pleased to report that although it has been an exceptionally turbulent six months, with the global economy and stock markets facing disruption and uncertainty of a magnitude unprecedented in recent years, the Company has produced a NAV total return of 6.1% in the period to 30 June 2020, outperforming both the return of the Reference Index of 0.7% and of the peer group average of 3.1%, continuing the Company's record of outperformance. Strong stock selection has contributed significantly to this performance with quality stocks proving resilient, whilst some areas of focus in the portfolio, such as the internet and technology sectors, have proved to be beneficiaries of the business impact of the pandemic.

 

Further details on performance may be found in the Portfolio Managers' Review.

 

Promotion and discount control

 

Although the Company's shares were trading at a premium to NAV at the start of the period, the highly volatile trading conditions caused by the effects of the COVID-19 pandemic resulted in the share price falling to a discount of 3.5% as at 30 June 2020, with an average discount for the period of 2.5%.

 

The Company's discount management policy targets a discount to NAV of no more than 5% in normal market conditions and the board carefully monitors the share price in order to use the shareholder authority to buy back shares when appropriate. Following a spike in the discount in March, in the midst of market volatility caused by the pandemic, the Company began to purchase shares for holding in treasury. The first buyback was executed at a discount of just over 10% and the Company purchased shares on four subsequent occasions during the period, the last of which was at a discount of around 3.8%. Consequently the Company bought back 124,000 shares during the period and a further 56,508 shares have been bought back at a discount of around 3.5% since the end of the period. As at 9 September, the discount had narrowed to 2.0%.

 

Gearing

 

The portfolio managers have proactively utilised gearing over the period which has contributed to the strong performance. Although the level of gearing started the year at 2.2% this was increased close to the point that markets bottomed in late March to end the period at 11.3%. Having taken advantage of the very substantial rally in global markets during the second quarter of the year the level of gearing has subsequently been reduced to the current level of 8.1% (as at 9 September).

 

Shareholder engagement

 

Although the Company's AGM was held behind closed doors due to the government restrictions on public gatherings during the pandemic, the Company's portfolio manager prepared a presentation, which was made available on the Company's webpages (www.schroders.co.uk/satric).

 

Shareholders are welcome to get in touch with the board with any queries, through the Company Secretary (details on the back cover of the Half Year Report), and for regular news about the trust, shareholders are also encouraged to sign up to the Manager's investment trusts update by visiting the Company's website www.schroders.com/en/uk/private-investor/fund-centre/funds-infocus/investment-trusts/schroders-investmenttrusts/never-miss-an-update/.

 

Outlook

 

It is an achievement to have delivered positive returns in the last six months despite extremely challenging market conditions, but the repercussions of COVID-19 are likely to continue to have a negative impact on global economies and stock markets both for the remainder of this year and looking further forward. As news of the pandemic hopefully abates, the ongoing concern over US/China trade relations, national security issues in Hong Kong and the US elections in November are likely to continue to cause uncertainty.

 

The portfolio managers have become more cautious although trading conditions are unlikely to be as volatile as earlier in the year. Valuations for some specific sectors of the market now look steep following very strong performance, although there are still quality stocks to be found at reasonable value. Markets may have to digest successive downward revisions in corporate earnings as the effects of COVID-19 are reflected in company profit forecasts. However this environment provides ample opportunity for stock pickers as benchmark moves belie huge earnings dispersion both within and between sectors. In addition, the portfolio managers' focus on long-term fundamental growth companies in Asia with strong balance sheets and sound corporate governance should provide portfolio resilience, with the added benefit of being able to utilise capital protection against downside risk.

 

Sarah MacAulay

Chairman

 

10 September 2020

 

Portfolio Managers' Review

 

Performance

 

The first half of 2020 saw some of the most volatile movements in stock market history as the world battled with the coronavirus pandemic. As the virus outbreak spread in February from a China issue to a global problem, most Asian countries went into some form of economic lockdown. Investors witnessed the end of a 10 year record-breaking stock market bull run in the USA, which was followed in March by one of the sharpest market crashes in history. Nevertheless, despite the still uncertain near-term economic outlook, markets from early April rebounded strongly as investors were willing to look through the current slump in earnings and towards a more normalized operating environment in 2021. This widespread optimism in markets was also underpinned by the unprecedented efforts by global governments and central banks who stepped in with rounds of fiscal and monetary stimulus to backstop the economy and financial markets.

 

The portfolio suffered a sharp pull-back in Q1 as the broader market corrected sharply and braced for the uncertain economic impact from measures to combat the COVID-19 pandemic. This was followed by an equally sharp recovery in Q2 as investors' panic started easing on signs of the infection "curves" flattening in most European, North American and Asian countries. After a difficult Q1, the portfolio's performance rebounded strongly, recouping all of the Q1 losses by early June and then putting on some net gains for the first half of 2020. Overall the NAV returned 6.1% versus the Reference Index's 0.7% (MSCI AC Asia Pacific ex Japan index, source Morningstar).

 

Over the six months, stock selection in China, Taiwan, Singapore and Australia was amongst the notable positive contributors. Companies in the internet and technology sectors generally held up better during the initial sell-off given the limited impact from the lockdowns on their business models. These sectors then led the subsequent rebound as the markets expect to see an accelerated shift to more online activities and technology usage as a result of the pandemic.

 

Many of our technology holdings such as Sea, Seek, Tencent, MediaTek, Chroma Ate, and TSMC performed well and were among the key contributors. In Australia, performance was helped by strong performance from healthcare names (Cochlear, ResMed, CSL). A key positive was also the limited exposure to oil and gas, banking and heavy industrial stocks which were the weakest performing. Similarly, due to our long-term concerns on competitiveness, the portfolio only owns a handful of Indian and ASEAN stocks which were the weakest markets, finishing the first half in negative territory.

 

The exposure to domestic Hong Kong was negative owing to worries over collateral damage from the heightened Sino-US tensions, especially following the enactment of the controversial National Security Law in the city. Finally, not holding some of the second-tier or emerging Chinese E-commerce names such as Meituan and Pinduoduo also slightly dragged on performance relative to the Reference Index, as these share prices more than doubled, driven partly by retail sentiment as markets turned increasingly frothy.

 

On capital protection, our small position in put options on the HK and Chinese indices helped offset a little of the negative returns during the sell-off (puts being an option to sell assets at an agreed price). As the crisis unfolded and markets priced in an increasingly negative outlook, we closed most of the hedges. At the end of March our model readings turned strongly positive on markets and we raised gearing levels moderately to a peak of around 12%, which allowed a fuller participation in the subsequent market recovery.

 

Post the end of the period covered in this report, markets have continued to bounce strongly despite the cautious outlook on corporate earnings for many sectors. We have reduced gearing and are now starting to look to add some level of protection via put options.

 

Outlook

 

With COVID-related demand destruction still very prevalent, given the rapid spread of COVID-19 in many emerging countries and the risks of secondary spikes in developed countries, profits in many sectors in Asia will continue to face significant near term headwinds. Nevertheless, the recent sharp recovery in markets shows that many investors are instead placing a great deal of hope on a 2021 recovery, along with the reassurance that central bankers and politicians will do "whatever it takes" to backstop the economy and markets. Or perhaps many investors now correctly recognise that if doing whatever it takes means money printing, then equities may be preferable to cash…

 

The recent optimism has led to some outsized gains within selected parts of the markets. In particular Chinese A-shares have been looking increasingly frothy since May, and this froth has now spilled over into the broader China markets (as proxied by the MSCI China index in the chart below) and now appears to be spreading to parts of the Taiwanese and Korean equity markets.

 

The driver of the recent moves in the Chinese and North Asian markets has principally been domestic retail investors. As shown in Chart 3 and 4 the turnaround in domestic retail sentiment in Asia has been quite dramatic since the end of March, with significant retail investor buying. Margin balances are also rising sharply (Chart 5) and some of the recent IPOs in Hong Kong are running at oversubscription rates of 200-300 times, the typical levels at the peak of past speculative fervours (Chart 6) in Asia. It would be fair to say the traffic lights are very much flashing amber - and we believe caution is warranted at this point.

 

With bubbles seemingly spreading in pockets of the market, we need to ask ourselves a few questions:

 

1. So how big is the bubble?

 

2. How dangerous is the bubble?

 

3. How long might it last?

 

How big is the bubble?

 

The bubble at the moment is not that broad-based, but in some sectors this froth has now become worrying as prices appear to have risen to unsustainable levels. This bubble has some parallels with the TMT bubble of 1999/2000, and it appears to be concentrated in stocks related to the "BEVI" sectors:

 

B - Biotech and any related pharma stocks - ideally those with no revenues and just a pipeline of hopes and dreams.

 

EV - Any stock that makes a widget, valve, semiconductor, or battery that might be used in an electric car - and of course particularly a Tesla. It doesn't matter if they have orders, just as long as they can talk about potential ones at an indeterminate date in the future.

 

I - Internet and any tech companies that can claim they have an internet, cloud, e-commerce, working from home, mobile gaming angle. Ideally, you want companies where losses are still expanding, ideally even faster than revenues and where the model is "new" and untested, but just bound to be loved by Generation Z.

 

For those who can recall 1999/2000, the current environment will bring back memories of the TMT bubble. And of course, true to form, the ever-creative sell side are creating new valuation measures and challenging each other to come up with sillier price targets for many stocks in these sectors.

 

The bubble-like conditions in these sectors are quite big for some individual stocks. Biotech stocks are probably the silliest. There are plenty of examples, but a couple stood out for us. One has quadrupled its market cap since its IPO in mid-June; it has no revenues and just a pipeline of which only one or two drugs look potentially material as of today.

 

Another biotech firm's share price has risen over 20 times this year. We've struggled to find much information about its business, but this firm with a market cap of $6 billion appears to have 60 employees and no revenues.

 

How dangerous is this bubble?

 

Up until early July, the excesses were mostly concentrated in second tier companies, so we were reasonably relaxed that the downside risk overall was not huge. However, we are getting increasingly concerned about the internet sector, particularly in China. China is c.40-50% of most of the standard benchmarks used by Asian funds and internet stocks on their own are around 40-45% of the MSCI China index. So a bubble spreading to this sector does create risks of significant market falls.

 

Initially, with Chinese tech giants Alibaba and Tencent not participating in the froth, we felt relaxed that overall market risks was not serious, but these two have now joined the party. In the first week of July Alibaba's market value rose by US$120bn, approximately the combined value of HSBC Bank and Jardine Matheson.

 

So alarm bells are ringing. At least for Alibaba and Tencent, the network effects and investment strategies of these companies may justify some of the strength in their share prices. For many other internet names, though, a clear speculative fervour has taken hold. We question whether network effects that you get in e--commerce, online media etc. are anywhere near as strong in bike-sharing, taxis, food delivery, hotel booking, group buying and so on. Certainly in the US it is very much the case that "not all internet stocks are created equal". Will China be so different?

 

Many other sectors are moribund. ASEAN markets are struggling, Australia is doing nothing; property, banks, cyclicals, industrials, oil & gas remain very out of favour. This again is similar to the bubble at the turn of the century. The retail investor only wants to chase hot themes and stories.

 

So how worried should we be and how long might these conditions last?

 

As highlighted above, with the froth spreading to wider areas of internet and technology, we are now concerned about risks to the downside. Our feeling, purely based on past experience of retail bubbles in Asia, is this will get bigger before it bursts. We would expect, however, the bubbly conditions to remain pretty confined to the BEVI sectors.

 

For those willing to look away from the herd, opportunities in Asia are to be had, such as in great bank franchises or quality resource stocks offering a 7% dividend yield… but that is so passé of course…

 

So what are your portfolio managers doing?

 

At current levels, our model is forecasting flat markets. Our valuation indicators are also back at neutral levels as the rerating in the internet, technology and pharma sectors offsets the optically "cheap" sectors such as banks, property, insurance, commodities and industrials.

 

Despite the froth in the BEVI sectors, much of the broader market is still lagging and remains reasonably valued. We therefore haven't been rushing to buy significant hedging, instead we remain disciplined and have trimmed stocks we hold that got pushed above our fair values on thematic excesses. If the bubble gets bigger and spreads to other sectors, we will look to add to hedging.

 

Meanwhile, in the short-term as we position the Company more defensively, this could mean potentially some periods of underperformance versus the Reference Index if frothy conditions continue.

 

Robin Parbrook, Lee King Fuei

 

10 September 2020

 

Principal risks and uncertainties

 

The principal risks and uncertainties with the Company's business fall into the following categories: strategic risk; investment management risk; custody risk; financial and currency risk; gearing and leverage risk; accounting, legal and regulatory risk; service provider risk; and cyber risk. A detailed explanation of the risks and uncertainties in each of these categories can be found on pages 31 to 33 of the Company's published annual report and accounts for the year ended 31 December 2019.

 

The board has continued to keep under review the effect of the COVID-19 pandemic on the Company's principal risk and uncertainties. Although it was assessed to be an emerging risk in the annual report, the board now considers that the Company's existing principal risks and uncertainties are sufficiently comprehensive. COVID-19 continues to affect the Company, affecting the value of the Company's investments due to the disruption of supply chains and demand for products and services, increased costs and cash flow problems, and changed legal and regulatory requirements for companies. The pandemic has had a significant impact on prospects for global growth as measured by GDP and it continues to create uncertainty in many sectors.

 

The board notes the Manager's investment process has been unaffected by the COVID-19 pandemic. The Manager continues to focus on long-term company fundamentals and detailed analysis of current and future investments. Nevertheless, the degree of uncertainty relating to investment management risk has increased due to COVID-19, and the board will be keeping this under close review.

 

COVID-19 also affected the Company's service providers, who implemented business continuity plans in line with government recommendations. However, the board has been pleased to note that to date the Company's service providers have been able to operate on a business as usual basis, despite the pandemic.

 

Except with respect to the degree of uncertainty relating to investment management risk, the Company's principal risk and uncertainties have not materially changed during the six months ended 30 June 2020.

 

Going concern

 

Having assessed the principal risks and uncertainties, and the other matters discussed in connection with the viability statement as set out on page 34 of the published annual report and accounts for the year ended 31 December 2019, as well as considering the effect of COVID-19 on those risks and, where appropriate, action taken by the Company's service providers in relation to those risks, detailed above, the directors consider it appropriate to adopt the going concern basis in preparing the accounts.

 

Related party transactions

 

There have been no transactions with related parties that have materially affected the financial position or the performance of the Company during the six months ended 30 June 2020.

 

Directors' responsibility statement

 

The directors confirm that, to the best of their knowledge, this set of condensed financial statements has been prepared in accordance with United Kingdom Generally Accepted Accounting Practice ("UK GAAP") and with the Statement of Recommended Practice, "Financial Statements of Investment Trust Companies and Venture Capital Trusts" issued in October 2019 and that this half year report includes a fair review of the information required by 4.2.7R and 4.2.8R of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Income Statement

 

 

 

(Unaudited)

For the six months

ended 30 June 2020

(Unaudited)

For the six months

ended 30 June 2019

(Audited)

For the year

ended 31 December 2019

 

 

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

 

Note

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Gains on investments held at fair value through profit or loss

 

-

13,948

13,948

-

47,079

47,079

-

47,073

47,073

Net gains/(losses) on derivative contracts

 

-

3,253

 3,253

-

(3,210)

(3,210)

-

(4,390)

(4,390)

Net foreign currency (losses)/gains

 

-

(941)

(941)

-

(97)

(97)

-

319

319

Income from investments

 

4,872

353

 5,225

4,481

376

 4,857

9,417

666

10,083

Other interest receivable and similar income

 

8

-

8

19

-

 19

32

-

32

Gross return

 

4,880

16,613

21,493

4,500

44,148

48,648

9,449

43,668

53,117

Investment management fee

 

(290)

(869)

(1,159)

(273)

(819)

(1,092)

(559)

(1,677)

(2,236)

Performance fee

 

-

-

-

-

(2,614)

(2,614)

-

(2,838)

(2,838)

Administrative expenses

 

(332)

-

(332)

(327)

-

(327)

(646)

-

 (646)

Net return before finance costs and taxation

 

4,258

15,744

20,002

3,900

40,715

44,615

8,244

39,153

47,397

Finance costs

 

(55)

 (166)

(221)

(59)

 (178)

(237)

(113)

(339)

 (452)

Net return on ordinary activities before taxation

 

4,203

15,578

19,781

3,841

40,537

44,378

8,131

38,814

46,945

Taxation on ordinary activities

3

1,095

-

 1,095

(189)

-

(189)

(478)

-

 (478)

Net return on ordinary activities after taxation

 

5,298

15,578

20,876

3,652

40,537

44,189

7,653

38,814

46,467

Return per share

4

5.41p

15.92p

21.33p

3.94p

43.74p

47.68p

8.10p

41.10p

49.20p

 

The "Total" column of this statement is the profit and loss account of the Company. The "Revenue" and "Capital" columns represent supplementary information prepared under guidance issued by The Association of Investment Companies. The Company has no other items of other comprehensive income, and therefore the net return on ordinary activities after taxation is also the total comprehensive income for the period.

 

All revenue and capital items in the above statement derive from continuing operations. No operations were acquired or discontinued in the period.

 

Statement of Changes in Equity

 

For the six months ended 30 June 2020 (Unaudited)

 

 

Note

Called-up

share

capital

£'000

Share

premium

£'000

Capital

redemption

reserve

£'000

Special

reserve

£'000

Capital

reserves

£'000

Revenue

reserve

£'000

Total

£'000

At 31 December 2019

 

4,895

60,135

 11,646

 29,182

234,828

 17,185

357,871

Repurchase of the Company's own shares into treasury

 

-

-

-

-

(436)

-

(436)

Net return on ordinary activities

 

-

-

-

-

 15,578

5,298

 20,876

Dividend paid in the period

5

-

-

-

-

-

(6,362)

(6,362)

At 30 June 2020

 

4,895

60,135

 11,646

 29,182

249,970

 16,121

371,949

 

For the six months ended 30 June 2019 (Unaudited)

 

 

 

Called-up

 

Capital

 

 

 

 

 

 

share

Share

redemption

Special

Capital

Revenue

 

 

 

capital

premium

reserve

reserve

reserves

reserve

Total

 

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 31 December 2018

 

4,570

37,081

 11,646

 29,182

196,014

 15,290

293,783

Issue of shares

 

142

9,894

-

-

-

-

 10,036

Net return on ordinary activities

 

-

-

-

-

 40,537

3,652

 44,189

Dividend paid in the period

5

-

-

-

-

-

(5,758)

(5,758)

At 30 June 2019

 

4,712

46,975

 11,646

 29,182

236,551

 13,184

342,250

 

For the year ended 31 December 2019 (Audited)

 

 

 

Called-up

 

Capital

 

 

 

 

 

 

share

Share

redemption

Special

Capital

Revenue

 

 

 

capital

premium

reserve

reserve

reserves

reserve

Total

 

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 31 December 2018

 

4,570

37,081

 11,646

 29,182

196,014

 15,290

293,783

Issue of shares

 

325

23,054

-

-

-

-

 23,379

Net return on ordinary activities

 

-

-

-

-

 38,814

7,653

 46,467

Dividend paid in the year

5

-

-

-

-

-

(5,758)

(5,758)

At 31 December 2019

 

4,895

60,135

 11,646

 29,182

234,828

 17,185

357,871

 

Statement of Financial Position

 

 

 

(Unaudited)

(Unaudited)

(Audited)

 

 

30 June

30 June

31 December

 

 

2020

2019

2019

 

Note

£'000

£'000

£'000

Fixed assets

 

 

 

 

Investments held at fair value through profit or loss

 

412,446

355,338

368,537

Current assets

 

 

 

 

Debtors

 

1,940

1,562

454

Cash at bank and in hand

 

-

4,641

4,202

Derivative financial instruments held at fair value through profit or loss

 

528

576

477

 

 

2,468

6,779

5,133

Current liabilities

 

 

 

 

Creditors: amounts falling due within one year

 

(42,965)

(19,867)

(15,799)

Net current liabilities

 

(40,497)

(13,088)

(10,666)

Total assets less current liabilities

 

371,949

342,250

357,871

Net assets

 

371,949

342,250

357,871

Capital and reserves

 

 

 

 

Called-up share capital

6

4,895

4,712

4,895

Share premium

 

 60,135

 46,975

 60,135

Capital redemption reserve

 

 11,646

 11,646

 11,646

Special reserve

 

 29,182

 29,182

 29,182

Capital reserves

 

249,970

236,551

234,828

Revenue reserve

 

 16,121

 13,184

 17,185

Total equity shareholders' funds

 

371,949

342,250

357,871

Net asset value per share

7

380.43p

363.21p

365.57p

 

Registered in England and Wales

Company registration number: 02153093

 

Cash Flow Statement

 

 

 

(Unaudited)

(Unaudited)

(Audited)

 

 

For the

For the

For the

 

 

six months

six months

year

 

 

ended

ended

ended

 

 

30 June

30 June

31 December

 

 

2020

2019

2019

 

Note

£'000

£'000

£'000

Net cash inflow from operating activities

8

661

2,587

6,697

Net cash outflow from investment activities

 

(26,707)

(20,475)

 (34,823)

Dividends paid

 

(6,362)

 (5,758)

 (5,758)

Interest paid

 

 (192)

(231)

(461)

Net bank loans drawn down

 

 11,979

4,350

 695

Repurchase of the Company's own shares into treasury

 

 (434)

-

-

Issue of new shares

 

-

9,576

23,379

Net cash outflow in the period

 

(21,055)

 (9,951)

 (10,271)

Reconciliation of net cash flow to movement in net funds

 

 

 

 

Net cash outflow in the period

 

(21,055)

(9,951)

(10,271)

Bank loan drawn down

 

(11,979)

(4,350)

(695)

Exchange movements

 

(941)

(97)

319

Changes in net funds arising from cash flows

 

(33,975)

(14,398)

(10,647)

Net (debt)/cash at the beginning of the period

 

(7,951)

2,696

2,696

Net debt at the end of the period

 

(41,926)

(11,702)

(7,951)

Represented by:

 

 

 

 

Cash at bank and in hand

 

(16,954)

4,641

4,202

Bank loans

 

(24,972)

(16,343)

(12,153)

Net debt

 

(41,926)

(11,702)

(7,951)

 

Notes to the Accounts

 

1. Financial Statements

 

The information contained within the accounts in this Half Year report has not been audited or reviewed by the Company's auditor.

 

The figures and financial information for the year ended 31 December 2019 are extracted from the latest published accounts of the Company and do not constitute statutory accounts for that year. Those accounts have been delivered to the Registrar of Companies and included the report of the auditors which was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Companies Act 2006.

 

2. Accounting policies

 

Basis of accounting

 

The accounts have been prepared in accordance with United Kingdom Generally Accepted Accounting Practice ("UK GAAP") and with the Statement of Recommend Practice "Financial Statements of Investment Trust Companies and Venture Capital Trusts" issued by the Association of Investment Companies in October 2019.

 

All of the Company's operations are of a continuing nature.

 

The accounting policies applied to these accounts are consistent with those applied in the accounts for the year ended 31 December 2019.

 

3. Taxation on ordinary activities

 

 

(Unaudited)

Six months ended

30 June 2020

(Unaudited)

Six months ended

30 June 2019

(Audited)

Year ended

31 December 2019

 

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Irrecoverable overseas tax

225

-

225

189

-

189

478

-

478

Recoverable corporation tax relating to prior years

(1,320)

-

(1,320)

-

-

-

-

-

-

Taxation on ordinary activities

(1,095)

-

(1,095)

189

-

189

478

-

478

 

The Company has reached an agreement with HMRC to recover £1,320,000 of corporation tax paid in relation to financial years 2007 and 2008. This represents a favourable outcome for the Company, following a dispute with HMRC over the treatment of overseas income.

 

The Company's effective corporation tax rate is nil, as deductible expenses exceed taxable income.

 

4. Return per share

 

 

(Unaudited)

(Unaudited)

 

 

Six months

Six months

(Audited)

 

ended

ended

Year ended

 

30 June

30 June

31 December

 

2020

2019

2019

 

£'000

£'000

£'000

Revenue return

5,298

3,652

7,653

Capital return

15,578

40,537

38,814

Total return

20,876

44,189

46,467

Weighted average number of shares in issue during the period

97,881,816

92,685,767

94,433,447

Revenue return per share

5.41p

3.94p

8.10p

Capital return per share

15.92p

43.74p

41.10p

Total return per share

21.33p

47.68p

49.20p

 

5. Dividend paid

 

 

(Unaudited)

(Unaudited)

 

 

Six months

Six months

(Audited)

 

ended

ended

Year ended

 

30 June

30 June

31 December

 

2020

2019

2019

 

£'000

£'000

£'000

2019 dividend paid of 6.5p (2018: 6.2p)

6,362

5,758

5,758

 

No interim dividend has been declared in respect of the year ended 31 December 2020 (2019: nil).

 

6. Called-up share capital

 

 

(Unaudited)

(Unaudited)

 

 

Six months

Six months

(Audited)

 

ended

ended

Year ended

 

30 June

30 June

31 December

 

2020

2019

2019

 

£'000

£'000

£'000

Changes in called-up share capital during the period were as follows:

 

 

 

Opening balance of ordinary shares of 5p each

4,895

4,570

4,570

Repurchase of shares into treasury

(6)

-

-

Issue of shares

-

142

325

Subtotal, ordinary shares of 5p each, excluding shares held in treasury

4,889

4,712

4,895

Shares held in treasury

6

-

-

Closing balance, ordinary shares of 5p each, including shares held in treasury

4,895

4,712

4,895

 

 

(Unaudited)

(Unaudited)

 

 

Six months

Six months

(Audited)

 

ended

ended

Year ended

 

30 June

30 June

31 December

 

2020

2019

2019

Changes in the number of shares in issue during the period were as follows:

 

 

 

Ordinary shares of 5p each, allotted, called-up and fully paid

 

 

 

Opening balance of shares in issue

97,895,159

91,400,159

91,400,159

Repurchase of shares into treasury

(124,000)

-

-

Issue of shares

-

2,830,000

6,495,000

Closing balance of shares in issue, excluding shares held in treasury

97,771,159

94,230,159

97,895,159

Closing balance of shares held in treasury

124,000

-

-

Closing balance of shares in issue, including shares held in treasury

97,895,159

94,230,159

97,895,159

 

7. Net asset value per share

 

 

(Unaudited)

(Unaudited)

 

 

Six months

Six months

(Audited)

 

ended

ended

Year ended

 

30 June

30 June

31 December

 

2020

2019

2019

Total equity shareholders' funds (£'000)

371,949

342,250

357,871

Shares in issue at the period end, excluding shares held in treasury

97,771,159

94,230,159

97,895,159

Net asset value per share

380.43p

363.21p

365.57p

 

8. Reconciliation of total return on ordinary activities before finance costs and taxation to net cash inflow from operating activities

 

 

(Unaudited)

(Unaudited)

 

 

Six months

Six months

(Audited)

 

ended

ended

Year ended

 

30 June

30 June

31 December

 

2020

2019

2019

 

£'000

£'000

£'000

Total return on ordinary activities before finance costs and taxation

20,002

44,615

47,397

Capital return on ordinary activities before finance costs and taxation

(15,744)

(40,715)

(39,153)

Increase in prepayments and accrued income

(174)

(848)

(166)

(Increase)/decrease in other debtors

1

(9)

(9)

(Decrease)/increase in other creditors

(2,690)

2,712

2,914

Special dividend allocated to capital

353

376

666

Stock dividend

-

-

(3)

Management fee allocated to capital

(869)

(819)

(1,677)

Performance fee allocated to capital

-

(2,614)

(2,838)

Overseas withholding tax deducted at source

(218)

(111)

(434)

Net cash inflow from operating activities

661

2,587

6,697

 

9. Financial instruments measured at fair value

 

The Company's financial instruments that are held at fair value include its investment portfolio and derivative financial instruments.

 

FRS 102 requires that these financial instruments are categorised into a hierarchy consisting of the following three levels:

 

Level 1 - valued using unadjusted quoted prices in active markets for identical assets.

 

Level 2 - valued using observable inputs other than quoted prices included within Level 1.

 

Level 3 - valued using inputs that are unobservable.

 

The following table sets out the fair value measurements using the above hierarchy:

 

 

30 June 2020 (unaudited)

 

Level 1

Level 2

Level 3

Total

 

£'000

£'000

£'000

£'000

 

 

 

 

 

Financial instruments held at fair value through profit or loss

 

 

 

 

Equity investments and derivative financial instruments

405,973

-

-

405,973

Participatory notes1

-

7,001

-

7,001

Total

405,973

7,001

-

412,974

 

30 June 2019 (unaudited)

 

Level 1

Level 2

Level 3

Total

 

£'000

£'000

£'000

£'000

Financial instruments held at fair value through profit or loss

 

 

 

 

Equity investments and derivative financial instruments

350,814

-

-

350,814

Participatory notes1

-

5,100

-

5,100

Total

350,814

5,100

-

355,914

 

31 December 2019 (audited)

 

Level 1

Level 2

Level 3

Total

 

£'000

£'000

£'000

£'000

Financial instruments held at fair value through profit or loss

 

 

 

 

Equity investments and derivative financial instruments

362,555

-

-

362,555

Participatory notes1

-

6,459

-

6,459

Total

362,555

6,459

-

369,014

 

1 Participatory notes, which are valued using the quoted bid prices of the underlying securities, have been allocated to Level 2 as, strictly, these are not identical assets.

 

10. Events after the interim period that have not been reflected in the financial statements for the interim period

 

The directors have evaluated the period since the interim date and have not noted any significant events which have not been reflected in the financial statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BRGDCCUBDGGG
Date   Source Headline
24th May 202411:44 amRNSNet Asset Value(s)
23rd May 202410:49 amRNSNet Asset Value(s)
22nd May 202410:56 amRNSNet Asset Value(s)
21st May 202410:50 amRNSNet Asset Value(s)
20th May 202410:41 amRNSNet Asset Value(s)
17th May 20245:26 pmRNSTransaction in Own Shares
17th May 202411:34 amRNSNet Asset Value(s)
16th May 202410:57 amRNSNet Asset Value(s)
15th May 202410:20 amRNSNet Asset Value(s)
14th May 202410:32 amRNSNet Asset Value(s)
13th May 202412:09 pmRNSNet Asset Value(s)
10th May 20245:20 pmRNSTransaction in Own Shares
10th May 202410:27 amRNSNet Asset Value(s)
9th May 202410:42 amRNSNet Asset Value(s)
8th May 202410:47 amRNSNet Asset Value(s)
7th May 202410:36 amRNSNet Asset Value(s)
3rd May 20244:42 pmRNSTransaction in Own Shares
3rd May 202410:55 amRNSNet Asset Value(s)
2nd May 202410:42 amRNSNet Asset Value(s)
1st May 20243:26 pmRNSPortfolio Update
1st May 202410:38 amRNSNet Asset Value(s)
30th Apr 20245:27 pmRNSTotal Voting Rights
30th Apr 20245:00 pmRNSDirector/PDMR Shareholding
30th Apr 202410:19 amRNSNet Asset Value(s)
29th Apr 202410:21 amRNSNet Asset Value(s)
26th Apr 20244:27 pmRNSTransaction in Own Shares
26th Apr 202410:45 amRNSNet Asset Value(s)
25th Apr 202410:41 amRNSNet Asset Value(s)
24th Apr 20245:13 pmRNSResult of AGM
24th Apr 202410:26 amRNSNet Asset Value(s)
23rd Apr 202411:07 amRNSNet Asset Value(s)
22nd Apr 202410:33 amRNSNet Asset Value(s)
19th Apr 20242:03 pmRNSDirector/PDMR Shareholding
19th Apr 202410:14 amRNSNet Asset Value(s)
18th Apr 202410:17 amRNSNet Asset Value(s)
17th Apr 202410:35 amRNSNet Asset Value(s)
16th Apr 202410:34 amRNSNet Asset Value(s)
15th Apr 20245:46 pmRNSDirector/PDMR Shareholding
15th Apr 20244:46 pmRNSPortfolio Update
15th Apr 202411:36 amRNSNet Asset Value(s)
15th Apr 20247:00 amRNSAppointment of Non-Executive Director
12th Apr 202410:53 amRNSNet Asset Value(s)
11th Apr 202410:27 amRNSNet Asset Value(s)
10th Apr 202410:24 amRNSNet Asset Value(s)
9th Apr 202411:03 amRNSNet Asset Value(s)
8th Apr 202411:18 amRNSNet Asset Value(s)
5th Apr 202410:24 amRNSNet Asset Value(s)
4th Apr 202410:56 amRNSNet Asset Value(s)
3rd Apr 202410:34 amRNSNet Asset Value(s)
2nd Apr 202411:09 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.